OS Therapies Shares Jump on $6 Million Private Placement

Dow Jones

2024-12-24

By Dean Seal

Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement.

The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58.

The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share.

The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

December 24, 2024 10:02 ET (15:02 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2493080165"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2493080165\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2493080165?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-24 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493080165","market":"sg","top_or_hot":-1,"title":"OS Therapies Shares Jump on $6 Million Private Placement","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OSTX\">OS Therapies</a> climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n</p>\n<p>\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n</p>\n<p>\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n</p>\n<p>\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 24, 2024 10:02 ET (15:02 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OS Therapies Shares Jump on $6 Million Private Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOS Therapies Shares Jump on $6 Million Private Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-24 23:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OSTX\">OS Therapies</a> climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n</p>\n<p>\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n</p>\n<p>\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n</p>\n<p>\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 24, 2024 10:02 ET (15:02 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2493080165","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493080165","pubTimestamp":1735052520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement.The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58.The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share.The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OSTX":"OS Therapies"},"translate_title":"OS Therapies股价因600万美元私募而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSTX":1},"content_text":"By Dean Seal \n\n\n \n\n\n  Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n\n\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n\n\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n\n\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2024 10:02 ET (15:02 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1}}}